Forgive my little foolishness but I do like to go back to past claims of how everything is running out and measuring them up against reality. And here's something from the New Scientist published back ...

If you can get rid of circulating tumor cells and tumor cell clusters that detach from a tumor, spreading the disease in the body, cancer is less likely to return. This is the hope behind a ...

At a research facility in Missouri, scientists are developing a new way to fight cancer that could change how some of the toughest tumors are treated. Using a radioactive substance called terbium-161, ...

BALTIMORE, June 15, 2021 /PRNewswire/ -- Deloitte announced today its acquisition of substantially all of the assets of Terbium Labs, a Baltimore-based digital risk protection company that helps ...

eSpeaks’ Corey Noles talks with Rob Israch, President of Tipalti, about what it means to lead with Global-First Finance and how companies can build scalable, compliant operations in an increasingly ...

A radioisotope produced at the University of Missouri Research Reactor holds promise for future cancer treatments. Carolyn Anderson and Heather Hennkens are leading the research project into how ...

New findings debunk previous wisdom that solid-state qubits need to be super dilute in an ultra-clean material to achieve long lifetimes. Instead, cram lots of rare-earth ions into a crystal, and some ...

At Terbium Labs, we pride ourselves on having a respectful work environment built around a diverse and accomplished team. Our backgrounds and experience draw from neuroscience, fashion, astronomy, ...

A new luminescent sensor can detect terbium, a valuable rare earth element used in smart phone displays, from complex environmental samples like acid mine waste. A new luminescent sensor can detect ...

A Baltimore-based company, Terbium Labs, has shone some light on the sort of content one can find on the so-called dark web, or at least that you can access through Tor. The study found, contrary to ...

The radiopharmaceutical consists of a radioactive molecule – in this case terbium-161 linked to a ligand. This ligand recognises proteins on the tumour cell, allowing highly targeted cancer treatment.